Adial Pharmaceuticals, Inc.
ADIL
$1.97
$0.147.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.98M | -8.05M | -8.45M | -8.95M | -13.20M |
| Total Depreciation and Amortization | 400.00 | 400.00 | 400.00 | 400.00 | 400.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.02M | 1.06M | 1.06M | 1.26M | 5.89M |
| Change in Net Operating Assets | 465.60K | 368.40K | 910.80K | 809.70K | 386.20K |
| Cash from Operations | -6.49M | -6.62M | -6.48M | -6.88M | -6.92M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 0.00 | 0.00 | 150.00K | -- |
| Other Investing Activities | 150.00K | 150.00K | 150.00K | -- | -- |
| Cash from Investing | 150.00K | 150.00K | 150.00K | 150.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.47M | 5.87M | 8.96M | 4.07M | 7.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.47M | 5.87M | 8.96M | 4.07M | 7.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.13M | -598.00K | 2.63M | -2.66M | 923.40K |